ArticleWorld journal of urology2025

Reply to the letter to the editor about "recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis" by Lundgren and Radros.

Andreas Karlsson Rosenblad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.